Various media have echoed the news about the Barcelona BioMed Conference on the use of the fly Drosophila melanogaster as a model to study cancer. Organised by IRB Barcelona with the support of the BBVA Foundation, the meeting will take place from 15 to 17 June in Barcelona. Marco Milán, ICREA researcher and head of the Development and Growth Control Laboratory, and Cayetano González, ICREA researcher and head of the Cell Division Laboratory, both at IRB Barcelona, have selected the 23 speakers who will participate in the conference.
In the conference “Drosophila as a model in cancer”, to be held from 15 to 17 June in Barcelona, IRB Barcelona and the BBVA Foundation bring together a select group of leading scientists that use the fruit fly for cancer research.
This fly can be used to study specific types of tumour, ranging from leukaemia to brain tumours, and complex processes such as metastasis or the wasting syndrome (extreme muscle weakness) associated with cancer. In addition, Drosophila has proved to be an excellent tool for drug screening in vivo.
Nobert Perrimon is among the invited speakers. From his lab at Harvard, he has performed one of the largest screenings of molecules in flies in search of new anti-tumour applications of drugs that have already been approved by the FDA.
Special mention is also given to the participation of Sam Jackson, from the National Center for the Replacement, Refinement and Reduction of Animals in Research, a British organisation that promotes and supports the use of invertebrate models, such as Drosophila, for cancer research.
The two-day workshop is part of the Teachers and Science programme, organised by the Catalunya-La Pedrera Foundation. This year’s programme will involve the participation of nine research centres from around Catalonia
The overall objective is to improve science teaching in order to increase scientific vocation among students
The IRB Barcelona workshop is dedicated to biomedical research with fruit flies
This year IRB Barcelona has supervised 39 research projects done by secondary school students
The awardees will present their work in two public science fairs to be held this year
Diario Médico echoes on an article about nutrition developed by Lara Barrio and Marco Milán in the Development and Growth Control laboratory. The work was published in Cell Reports.
Scientists at IRB Barcelona have observed that, when deprived of food, flies that do not express p53 show poor management of energy store.
The study, published today in Cell Reports, further supports the involvement of this molecule—traditionally associated with tumour suppression—in metabolism.
The researchers provide new insights to study p53 function in metabolic diseases such as diabetes and obesity.
The "Diario Médico" reports on statements by Marco Milán on the uses of Drosophila melanogaster to study diseases such as cancer and autoimmune conditions. Milán coorganised the European Drosophila Research Congress, which was held in Barcelona from 16 to 19 October.
Read the news in "Diario Médico" (PDF in Spanish)
On 16-19 October, 700 scientists will meet for the 23 European Drosophila Conference in the Palau de Congressos in Barcelona.
Drosophila melanogaster, also known as the fruit fly, is a key model organism in genetics and essential for our understanding of disease.
Jules Hoffmann, French researcher and 2011 Nobel Laureate in Medicine, will deliver the opening plenary lecture on Wednesday afternoon.
Barcelona hosts a large concentration of biomedical research groups specialized in Drosophila, making the city a European and worldwide reference for this area of research.
• The study, published in Current Biology, links growth to sexual maturity.
• Scientists at IRB Barcelona identify a micro-RNA key to insulin’s regulation of steroid hormones in flies.
A study by Marco Milán’s group published in the journal Proceedings of the National Academy of Sciences USA (PNAS) has received attention from several media channels. Performed in the fly Drosophila melanogaster, the study reports on some of the molecular and cellular processes behind the transformation of a healthy cell into a tumour cell. The findings pave the way to understanding the details of the processes described.
Read the news in El Periódico de Catalunya (PDF in Catalan)